Technology
Tech Mahindra and NVIDIA Collaborate to Advance Drug Safety with Agentic AI-Powered Pharmacovigilance Solution
Tech Mahindra (NSE: TECHM), a leading global provider of technology consulting and digital solutions to enterprises across industries, announced a pharmacovigilance (PV) autonomous solution built with NVIDIA AI software to advance drug safety management. The transformative solution leverages agentic artificial intelligence (AI) and automation to enhance the accuracy, speed, and efficiency of pharmacovigilance processes, addressing critical industry challenges such as manual delays and data overl
About this update from Tech Mahindra Limited
[{"type":"text","content":"PUNE, India, March 19, 2025 /PRNewswire/ -- Tech Mahindra (NSE: TECHM), a leading global provider of technology consulting and digital solutions to enterprises across industries, announced a pharmacovigilance (PV) autonomous solution built with NVIDIA AI software to advance drug safety management. The transformative solution leverages agentic artificial intelligence (AI) and automation to enhance the accuracy, speed, and efficiency of pharmacovigilance processes, addressing critical industry challenges such as manual delays and data overload.","length":553,"tagName":"p"},{"type":"image","alt":"Tech Mahindra Logo","displaySize":"","headline":null,"caption":"Tech Mahindra Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":110,"url":"https://media.zenfs.com/en/prnewswire.com/d57ecad8e770ed99314a674215d07fb1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/9NZZwcbBGBY2ehLucbGa8Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE5NDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/d57ecad8e770ed99314a674215d07fb1","width":400,"height":110}}},{"type":"text","content":"Powered by Tech Mahindra's TENO framework, which is built on NVIDIA's cutting-edge AI technology, the solution is designed to automate and optimize pharmacovigilance workflows. By integrating the NVIDIA AI Enterprise software platform, including NVIDIA NeMo™, NVIDIA NIM™ microservices, and NVIDIA AI Blueprints, the Tech Mahindra solution streamlines case intake, data transformation, quality control, and compliance management, thereby ensuring a seamless and intelligent PV workflow. Additionally, the LLM-powered AI agents within the solution autonomously handle case classification, prioritization, and verification of pharmacovigilance emails to reduce the risk of human error.","length":691,"tagName":"p"},{"type":"text","content":"Nikhil Malhotra, Chief Innovation Officer & Global Head of AI and Emerging Technologies, Tech Mahindra, said, "As the pharmaceutical industry navigates volumes of data during trials and post-launch, our collaboration with NVIDIA leverages generative AI and multi-agent systems to streamline pharmacovigilance process. Together, we are revolutionizing drug safety management and using the innovative AI-driven framework to develop multiple use cases for our global customers."","length":489,"...